Last reviewed · How we verify
NCT06831773
Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma
NA trial testing Carbon ion combined with photon radiotherapy in Carbon Ion Radiotheray in 23 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | Gansu Wuwei Tumor Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 23 |
| Start date | 1 February 2025 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- Carbon ion combined with photon radiotherapy
Conditions studied
- Carbon Ion Radiotheray — all drugs for Carbon Ion Radiotheray →
- High-grade Glioma — all drugs for High-grade Glioma →
- Heavy Ion Radiotherapy — all drugs for Heavy Ion Radiotherapy →
Sponsor
Gansu Wuwei Tumor Hospital
Who can join
Adults 14 to 80, any sex, with Carbon Ion Radiotheray or High-grade Glioma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective is to use the advantages of heavy ion physical dosimetry and biology to improve the tumor control rate and long-term survival rate of high-grade glioma, reduce the occurrence of brain tissue radiation damage caused by increasing prescription dose, and provide new treatment suggestions for glioma radiotherapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06831773
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Carbon Ion Radiotheray
Currently open trials in the same condition.
- NCT06311955 — Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor · Phase 2 · recruiting
Other Gansu Wuwei Tumor Hospital trials
Trials by the same sponsor.
- NCT06840067 — Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06831773 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gansu Wuwei Tumor Hospital
- Last refreshed: 18 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06831773.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing